References
- Azziz R, Marin C, Hoq L, et al. Healthcare-related economic burden of the polycystic ovary syndrome (PCOS) during the reproductive lifespan. J Clin Endocrinol Metab 2005;90:4650–8
- Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008;26:72–84
- Cibula D, Cifkova R, Fanta M, et al. Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of polycystic ovary syndrome. Hum Reprod 2000;15:785–9
- Liu Z. The renin-angiotensin system and insulin resistance. Curr Diab Rep 2007;7:34–42
- Leung PS. Intrinsic angiotensin-generating system: its tissue specific functions and clinical implications. Panminerva Med 2002;44:93–7
- Wu X, Lu K, Su Y. Renin-angiotensin system: involvement in polycystic ovarian syndrome. Zhonghua Fu Chan Ke Za Zhi 1997;32:428–31
- Lau T, Carlsson PO, Leung PS. Evidence for a local angiotensin-generating system and dose-dependent inhibition of glucose-stimulated insulin release by angiotensin II in isolated pancreatic islets. Diabetologia 2004;47:240–8
- Bernini GP, Bela S, Cionini R, et al. Aldosterone and renin plasma levels in young patients with polycystic ovary syndrome. Endocrine Abstracts 2006;11:P692
- Uncu G, Sözer MC, Develioğlu O, Cengiz C. 2The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS. Gynecol Endocrinol 2002;16:447–52
- Yanes LL, Davis D, Romero DG, Reckelhoff JF. Activation of Angiotensin II mediated hypertension in a rat model of polycystic ovary syndrome. FASEB J 2010;24 (Meeting abstract supplement) 1041.14
- Bednarek-Tupikowska G, Zdrojewicz Z. Activity of the enzyme converting angiotensin I to angiotensin II (ACE) in patients with polycystic ovary syndrome. Endokrynol Pol 2003;44:169–74
- Sharifi AM, Darabi R, Akbarloo N, et al. Investigation of circulatory and tissue ACE activity during development of lead-induced hypertension. Toxicol Lett 2004;153:233–8
- Sharifi AM, Akbarloo N, Darabi R, Larijani B. Study of correlation between elevation of blood pressure and tissue ACE activity during development of hypertension in 1K1C rats. Vasc Pharmacol 2004;41:15–20
- Sharifi AM, Akbarloo N, Heshmatian B, Ziai A. Alteration of local ACE activity and vascular responsiveness during development of 2K1C renovascular hypertension. Pharmacol Res 2003;47:201–9
- Sharifi AM, Akbarloo N, Darabi R. Investigation of local ACE activity and structural alterations during development of L-NAME-induced hypertension. Pharmacol Res 2005;52:438–44
- DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454–60
- Lu XE, Huang HF, Li MG, et al. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles. J Zhejiang Univ Sci B 2005;6:897–902
- Ainslie GM, Benatar SR. Serum angiotensin converting enzyme in sarcoidosis: sensitivity and specificity in diagnosis: correlations with disease activity, duration, extra-thoracic involvement, radiographic type and therapy. Q J Med 1985;55:253–70